Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
248 studies found for:    Exclude Unknown | Expanded Access Studies
Show Display Options
Rank Status Study
21 No longer available Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Condition: Prostatic Neoplasms
Intervention: Drug: Radium-223 dichloride (BAY88-8223)
22 Available Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Condition: Hypertension, Pulmonary
Intervention: Drug: Adempas (Riociguat, BAY63-2521)
23 No longer available Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Condition: HIV Infections
Interventions: Drug: Tipranavir;   Drug: Ritonavir
24 No longer available Fosamprenavir Expanded Access
Condition: HIV Infection
Interventions: Drug: fosamprenavir;   Drug: Telzir®
25 No longer available Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy
Condition: Metastatic Renal Cell Cancer
Intervention: Drug: Everolimus
26 Available Prevention of Transmission of Sexually Transmitted Diseases in the Youth Through Effective Intervention,
Condition: HIV
Intervention: Behavioral: Lifestyle Counseling
27 Approved for marketing Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Pomalidomide
28 Approved for marketing Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Biological: adalimumab
29 Available An Open Label Access Study For Subjects Who Completed A1481156
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Access program
30 No longer available An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
Condition: HIV Infections
Intervention: Drug: Tipranavir
31 Available Use Massive Parallel Sequencing and Exome Capture Technology to Sequence the Exome of Fanconi Anemia Children and Their Patents
Conditions: Fanconi Anemia;   Autosomal or Sex Linked Recessive Genetic Disease;   Bone Marrow Hematopoiesis Failure, Multiple Congenital Abnormalities, and Susceptibility to Neoplastic Diseases.;   Hematopoiesis Maintainance.
Interventions: Genetic: human whole exome;   Genetic: whole genomic
32 Available Expanded Access Program With Nivolumab for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Systemic Treatment Containing an Anti_CTLA-4 Monoclonal Antibody (CheckMate 168)
Condition: Stage III (Unresectable) or Stage IV Advanced Melanoma
Intervention: Drug: Nivolumab
33 No longer available Buphenyl Therapy for Byler's Disease
Condition: Byler Disease
Intervention: Drug: Buphenyl
34 Approved for marketing Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C
Condition: Post-transplant Hepatitis C
Interventions: Drug: Sofosbuvir;   Drug: Ribavirin;   Drug: Pegylated Interferon
35 Available Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD
Conditions: Graft vs Host Disease;   Graft-Versus-Host Disease
Intervention: Biological: remestemcel-L
36 Temporarily not available Pulmonary Vein Isolation Outcomes With Fish Oils
Condition: Atrial Fibrillation
Intervention: Drug: Lovaza (Fish Oils)
37 Available Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Condition: Unresected Stage IIIb to IVM1c Melanoma
Intervention: Drug: Talimogene Laherparepvec
38 No longer available Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
Conditions: Metastatic Liver Cancer;   Ocular Melanoma;   Cutaneous Melanoma
Interventions: Drug: Melphalan;   Device: Percutaneous Hepatic Perfusion
39 Temporarily not available An Open-Label Treatment Protocol With UX003 rhGUS Enzyme Replacement Therapy for an Advanced Stage MPS 7 Patient
Condition: Mucopolysaccharidosis Type 7
Intervention: Drug: UX003
40 Temporarily not available 99m-Technetium- Glucosamine in Arthritis
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis
Intervention: Device: Technetium labelled glucosamine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years